Why the study?
Are low molecular weight heparins safe and effective for the prevention of thromboembolic complications in obstetrics and gynecology?
Population
Patients in obstetrics and gynecology, including those undergoing gynecologic surgery and pregnant women
Design
Review
Authors
Loading...
Supports LMWH consideration for thromboprophylaxis in obstetrics and gynecology; leaves open need for randomized confirmation.
Are low molecular weight heparins safe and effective for the prevention of thromboembolic complications in obstetrics and gynecology?
Low molecular weight heparins appear to be a safe and effective option for thromboprophylaxis in obstetrics and gynecology, offering advantages such as reduced bleeding risk and lack of placental transfer.
Fejgin et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: